Big pharma, big data: Why drugmakers want your health records

  • TECH Premium
  • Sunday, 04 Mar 2018

FILE PHOTO: A surgery nurse is seen beside the heart beat monitor in the operating theatre of the Unfallkrankenhaus Berlin (UKB) hospital in Berlin, Germany February 29, 2008. REUTERS/Fabrizio Bensch /File Photo

LONDON: Drugmakers are racing to scoop up patient health records and strike deals with technology companies as big data analytics start to unlock a trove of information about how medicines perform in the real world. 

Studying such real-world evidence offers manufacturers a powerful tool to prove the value of their drugs – something Roche aims to leverage, for example, with last month's US$2bil (RM7.81bil) purchase of Flatiron Health. 

Article type: metered
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

Next In Tech News

Microsoft blockbuster takeover upends video game market Premium
Poland raises cyberattack threat level after Ukraine incident Premium
Sony falls most in almost two years on Microsoft-Activision deal Premium
Olympic athletes told to leave phones at home to dodge spying Premium
AT&T, Verizon agree to delay 5G implementation at some airports Premium
Bobby Kotick: Embattled Activision CEO faces uncertain future Premium
Honda signs joint development pact with Boston-based EV battery R&D firm SES Premium
Five reasons Microsoft is making Activision Blizzard its biggest deal ever Premium
Sony slides on 'monumental challenge' from Microsoft gaming deal Premium
AI can make it easier to detect fractures Premium

Others Also Read